Investors Pump $257M Into Thrive’s Liquid Biopsy Test
Thrive is developing CancerSEEK, a liquid biopsy test designed to detect cancers at earlier stages of disease.
Thrive is developing CancerSEEK, a liquid biopsy test designed to detect cancers at earlier stages of disease.